Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells
Intracellular Ca(2+) signaling is important for stem cell differentiation and there is evidence it may coordinate the process. Arginine vasopressin (AVP) is a neuropeptide hormone secreted mostly from the posterior pituitary gland and increases Ca(2+) signals mainly via V1 receptors. However, the role of AVP in adipogenesis of human adipose-derived stem cells (hASCs) is unknown. In this study, we identified the V1a receptor gene in hASCs and demonstrated that AVP stimulation increased intracellular Ca(2+) concentration during adipogenesis. This effect was mediated via V1a receptors, Gq-proteins and the PLC-IP3 pathway. These Ca(2+) signals were due to endoplasmic reticulum release and influx from the extracellular space. Furthermore, AVP supplementation to the adipogenic medium decreased the number of adipocytes and adipocyte marker genes during differentiation. The effect of AVP on adipocyte formation was reversed by the V1a receptor blocker V2255. These findings suggested that AVP may function to inhibit adipocyte differentiation.
Publication Source (Journal or Book title)
Molecular and cellular endocrinology
Tran, T. D., Yao, S., Hsu, W. H., Gimble, J. M., Bunnell, B. A., & Cheng, H. (2015). Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells. Molecular and cellular endocrinology, 406, 1-9. https://doi.org/10.1016/j.mce.2015.02.009